Singapore markets close in 4 hours 36 minutes

Straits Times Index
3,166.97
+13.74(+0.44%)
Nikkei
27,363.89
+243.36(+0.90%)
Hang Seng
18,010.18
-77.79(-0.43%)
FTSE 100
7,052.62
-33.84(-0.48%)
BTC-USD
20,399.99
+201.50(+1.00%)
CMC Crypto 200
463.55
+5.14(+1.12%)

Super-rich China hotpot tycoons pile into Singapore’s good class bungalows

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

28.09

-0.13

(-0.46%)

At close: 04:00PM EDT

26.68

-1.41

(-5.02%)

After hours:

04:30PM EDT

Loading interactive chart…

Zacks
SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal
SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult patients with progressing desmoid tumors, meets primary and key secondary endpoints.
Zacks
Allogene (ALLO) Focuses on Pipeline Amid Lack of Marketed Drugs
With no product revenues due to the lack of marketed drugs, Allogene (ALLO) focuses on developing its pipeline candidates that mainly consist of allogenic CAR T therapies.
Zacks
SpringWorks (SWTX) & AbbVie Unite for Multiple Myeloma Drug
SpringWorks Therapeutics (SWTX) collaborates with AbbVie (ABBV) to evaluate the combination of nirogacestat with AbbVie's ABBV-383 for relapsed or refractory multiple myeloma.